Caffeine for the management of apnea in preterm infants

International Health

Volumn 1, Issue 2, 2009, Pages 190-195

  Mueni, Eunice ^a   Opiyo, Newton ^a   English, Mike ^a,b  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Apnea; Caffeine; Infant; Prematurity

Indexed keywords

AMINOPHYLLINE; CAFFEINE; CAFFEINE CITRATE; CITRATE SODIUM; CITRIC ACID; METHYLXANTHINE; PLACEBO; THEOPHYLLINE;

APNEA; ARTICLE; ARTIFICIAL VENTILATION; CEREBRAL PALSY; COGNITIVE DEFECT; DRUG CHOICE; DRUG COST; DRUG FORMULATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; GESTATIONAL AGE; HUMAN; INFANT; KENYA; LOADING DRUG DOSE; MEDICAL LITERATURE; NEWBORN APNEA; NEWBORN MORTALITY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SURVIVAL; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 71649103838     PISSN: 18763413     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.inhe.2009.09.005     Document Type: Article

References (25)

1. Schmidt B., Roberts R.S., Davis P., Doyle L.W., Barrington K.J., Ohlsson A., Solimano A., and Tin W. Caffeine therapy for apnea of prematurity. N Engl J Med 354 (2006) 2112-2121
2. WHO. WHO Pocket Book of Hospital Care for Children: guidelines for the management of common illnesses with limited resources. Available at www.ichrc.org (accessed 10 February 2009).
3. Mehta V.B., and Robert E.S. Treatment of apnea of prematurity. Pediatric Drugs 5 (2000) 195-210
4. Hochwald C., Kennedy K., Chang J., and Moya F. A randomized, controlled, double- blind trial comparing two loading doses of aminophylline. J Perinatol 22 (2002) 275-278
5. Erenberg A., Leff R.D., Haack D.G., Mosdell K.W., Hicks G.M., and Wynne B.A. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo- controlled study. Pharmacotherapy 20 (2000) 644-652
6. Steer P.A., and Henderson-Smart D.J. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev 2 (2000) CD000273
7. Henderson-Smart D.J., and Steer P.A. Prophylactic methylxanthine for preventing of apnea in preterm infants. Cochrane Database Syst Rev 2 (2000) CD000432
8. Schmidt B., Roberts R.S., Davis P., Doyle L.W., Barrington K.J., Ohlsson A., Solimano A., and Tin W. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 357 (2007) 1893-1902
9. Henderson-Smart D.J., and Steer P.A. Prophylactic caffeine to prevent postoperative apnea following general anesthesia in preterm infants. Cochrane Database Syst Rev 4 (2001) CD000048
10. Murat I., Moriette G., Blin M.C., Couchard M., Flouvat B., De Gamarra E., Relier J.P., and Dreyfus-Brisac C. The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. J Pediatr 99 (1981) 984-989
11. Henderson-Smart D.J., and Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Database Syst Rev 3 (2001) CD000140
12. Scanlon J.E., Chin K.C., Morgan M.E., Durbin G.M., Hale K.A., and Brown S.S. Caffeine or theophylline for neonatal apnoea?. Arch Dis Child 67 (1992) 425-428
13. Bairam, Boutroy M.J., Badonnel Y., and Vert P. Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant. J Pediatr 110 (1987) 636-639
14. Brouard C., Morriette G., Murat I., Fluovat B., Pajot N., Walti H., de Gamarra E., and Relier J.P. Comparative Efficacy of Theophylline and Caffeine in the Treatment of Idiopathic Apnea in Premature Infants. Am J Dis Child 139 (1985) 698-700
15. Bucher H.U., and Duc G. Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial. Eur J Pediatr 147 (1988) 288-291
16. Levitt GA, Harvey DR. The use of prophylactic caffeine in the prevention of neonatal apnoeic attacks. Unpublished manuscript. Levitt GA, Mushin A, Bellman S, Harvey DR. Outcome of preterm infants who suffered neonatal apnoeic attacks. Early Hum Dev 1988; 16:235-243.
17. LeBard S.E., Kurth C.D., Spitzer A.R., and Downes J.J. Preventing postoperative apnea by neuromodulator antagonists. Anesthesiology 71 (1989) A1026
18. Welborn L.G., De Soto H., Hannallah R.S., Fink R., Ruttimann U.E., and Boeckx R. The use of caffeine in the control of post-anesthetic apnea in former premature infants. Anesthesiology 68 (1988) 796-798
19. Welborn L.G., Hannallah R.S., Fink R., Ruttimann U.E., and Hicks J.M. High-dose caffeine suppresses postoperative apnea in former preterm infants. Anesthesiology 71 (1989) 347-349
20. Davis P, Schmidt B, Robert R, Doyle L, Asztalos E, Haslam R, Sinha S, Tin W, The CAP investigators. Caffeine for apnea of prematurity (CAP) trial: benefits may vary in subgroups. Abstract of the paper presented in Hawaii in May 2008.
21. Neonatal Formulary 5: Caffeine Citrate (Comment). www.blackwellpublishing.com/medicine/bmj/nnf5/pdfs/comment/caffeine1.pdf (accessed 22 April 2009).
22. British National Formulary (BNF) for children, 2008. www.bnfc.org/bnfc/ (accessed 26 February 2009).
23. KEMSA. Kenya Medical Supplies Agencies (KEMSA). Available at: http://www.kemsa.co.ke/datagrids/kemsa_commodity_catalogue.php.
24. Joy L., and Kate K. Opportunities for Africa's newborns. Practical data, policy and pragmmatic support for newborn care for Africa. The Partnerships for Maternal. Newborn and Child Health (2006) 2006. http://www.who.int/pmnch/media/publications/africanewborns/en/index.html www.who.int/pmnch/media/publications/africanewborns/en/index.html (accessed 7 August 2009)
25. Lawn J.E., Cousens S., and Zupan J. Lancet Neonatal Survival Steering Team. 4 Million neonatal deaths: when? Where? Why?. Lancet 365 (2005) 891-900